Oct 9, 2026 08:01AM
Oct 9, 2026 08:00AM
Sep 29, 2026 08:02AM
Sep 29, 2026 08:00AM
Aug 7, 2026 08:45AM
May 20, 2026 04:45PM
May 8, 2026 08:45AM Atossa Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update
May 6, 2026 08:31AM
May 6, 2026 08:30AM
May 4, 2026 08:30AM
May 4, 2026 08:30AM
Mar 27, 2026 06:46AM
Mar 25, 2026 05:30PM
Mar 19, 2026 11:00AM The Patent Cliff is Coming, Driving Smart Money Towards Precision Oncology
Mar 19, 2026 08:00AM
Feb 11, 2026 08:31AM
Feb 11, 2026 08:30AM
Feb 5, 2026 08:31AM
Feb 5, 2026 08:30AM
Jan 16, 2026 04:40PM
Jan 6, 2026 08:15AM Atossa Therapeutics gets FDA clearance for breast cancer drug study
Jan 6, 2026 08:15AM
Dec 11, 2025 08:02AM
Dec 11, 2025 08:00AM
Dec 5, 2025 06:46AM
Dec 4, 2025 08:01AM
Dec 4, 2025 08:00AM
Nov 17, 2025 09:09AM Atossa highlights potential for endoxifen in muscular dystrophy treatment
Nov 17, 2025 09:07AM
Nov 12, 2025 08:15AM
Oct 7, 2025 06:47AM
Oct 1, 2025 08:32AM
Oct 1, 2025 08:30AM
Sep 9, 2025 06:52AM
Sep 8, 2025 08:30AM Atossa requests FDA meeting for endoxifen breast cancer drug development
Sep 8, 2025 08:30AM
Aug 28, 2025 08:30AM
Aug 20, 2025 08:30AM
Aug 12, 2025 08:30AM
Jul 29, 2025 07:45AM
Jul 29, 2025 07:45AM
May 20, 2025 09:00AM Join Atossa Therapeutics' Exclusive Live Investor Webinar and Q&A Session on May 22
May 14, 2025 08:15AM
May 13, 2025 08:00AM
Apr 30, 2025 08:45AM
Apr 30, 2025 08:45AM
Apr 29, 2025 08:47AM
Apr 29, 2025 08:45AM
Apr 22, 2025 08:45AM Atossa Therapeutics (ATOS) Issues New U.S. Patent
Apr 22, 2025 08:45AM

334,271 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All